NON-HODGKINS LYMPHOMA
Vysis LSI BIRC3/MALT1 DF FISH Probe Kit
For more information, contact Abbott.
For more information, contact Abbott.
| PRODUCT NAME | UNIT SIZE | ORDER NUMBER | GTIN |
|---|
The Vysis BIRC3/MALT1 DF FISH Probe Kit is intended to detect the t(11;18) (q21;q21) reciprocal translocation involving the BIRC3 (also know as API2) and MALT1 gene regions using the fluorescence in situ hybridization (FISH) technique.
The SpectrumOrange probe spans approximately 670 kb (chr18:54220804-54891192; March 2006 assembly) and covers the MALT1 gene region. The approximately 932 kb (chr11:101247706-102179265; March 2006 assembly) SpectrumGreen probe spans the BIRC3 gene region..
In a normal cell that lacks the t(11;18)(q21;q21) translocation, a two orange, two green signal pattern will be observed reflecting the two intact copies of MALT1 and BIRC3, respectively.
In an abnormal cell containing the t(11;18)(q21;q21) translocation, a one orange (MALT1), one green (BIRC3), and two fusion (BIRC3/MALT1 and MALT1/ BIRC3) signal pattern will be observed. Some samples containing the t(11;18) may display signal patterns differently than the one orange, one green, and two fusions.
Normal Hybridization: Result fo the hybridization of the LSI BIRC3/MALT1 Dual Color Dual Fusion Probes as observed in normal interphase cells.
Abnormal Hybridization: An abnormal cell hybridized with the LSI BIRC3/MALT1 Dual Color Dual Fusion Probes. The cell in this image shows the one orange, one green and two fusion signal pattern indicative of the t(11;18)(q21;q21) translocation.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.